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Background: The mortality rate of patients complicated with sepsis-associated organ failure remains high in spite
of intensive care treatment. The purpose of this study was to define the duration of systemic inflammatory
response syndrome (SIRS) before organ failure (DSOF) and determine the value of DSOF as a prognostic factor in
septic patients.
Methods: This retrospective cohort study was conducted in an 11-bed medical and surgical intensive care unit
(ICU) in a university hospital. The primary endpoint was in-hospital mortality of the septic patients.
Results: One hundred ten septic patients with organ failure and/or shock were enrolled in this study. The in-hospital
mortality rate was 36.9%. The median DSOF was 28.5 h. As a metric variable, DSOF was a statistically significant
prognostic factor according to univariate analysis (survivor: 74.7 ± 9.6 h, non-survivor: 58.8 ± 16.5 h, p = 0.015). On the
basis of the ROC curve, we defined an optimal cutoff of 24 h, with which we divided the patients as follows: group 1
(n = 50) comprised patients with a DSOF ≤24 h, and group 2 (n = 60) contained patients with a DSOF >24 h. There were
statistically significant differences in the in-hospital mortality rate between the two groups (52.0% vs. 25.0%, p = 0.004).
Furthermore, by multivariate analysis, DSOF ≤24 h (odds ratio: 5.89, 95% confidence interval: 1.46-23.8, p = 0.013) was a
significant independent prognostic factor.
Conclusion: DSOF may be a useful prognostic factor for severe sepsis.
Keywords: Severe sepsis, Septic shock, Systemic inflammatory response syndrome (SIRS), Organ failure, Acute Physiology
and Chronic Health Evaluation (APACHE) II scoreBackground
The mortality rate of patients complicated with sepsis-
associated organ failure or septic shock remains high in
spite of the treatments in intensive care units (ICU)
[1,2]. There are non-responders among the septic
patients with poor prognosis whose disease progresses
rapidly despite various treatments received in the ICU.
Previous reports show that certain scoring systems, in-
cluding the Acute Physiology and Chronic Health Evalu-
ation (APACHE) II score, Disseminated Intravascular
Coagulation (DIC) score, Sequential Organ Failure Assess-
ment (SOFA) score, and delta SOFA score, predict the
prognosis of sepsis [3-5]. However, they sometimes fail to
provide a prognosis for identifying high-risk patients with
sepsis at an early stage [6,7].* Correspondence: sugitaf@ba2.so-net.ne.jp
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in any medium, provided the original work is pSepsis is generally defined as systemic inflammatory re-
sponse syndrome (SIRS) with infection [8]. In most cases
of sepsis, patients only develop SIRS in the early stage, but
some of them (approximately 25%) progress to advanced
stages of the disease, which entail organ failure and septic
shock [9,10]. However, no study has sufficiently examined
the speed of progression from early stage sepsis to organ
failure and septic shock in the advanced stages. We defined
a novel parameter—the duration of SIRS before organ fail-
ure (DSOF) —which denotes the speed of sepsis progres-
sion. The purpose of this study was to determine whether
DSOF has prognostic value in septic patients complicated
with organ failure or shock.Methods
Patients and definition
This retrospective cohort study was conducted in the
medical and surgical ICU of a university hospital. Then Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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all enrollees gave their informed consent. From September
2001 to February 2007, 118 patients were enrolled. They
consist of the patients from the general ward of our hospital
and patients from other hospitals. They were transferred to
the ICU for treatment of sepsis.
Sepsis was defined as an infection with SIRS. Patients
were classified according to the American College of
Chest Physicians/Society of Critical Care Medicine Sepsis
Consensus Conference, 1992 [11].
We defined SIRS as the presence of at least two of the
following criteria: (1) body temperature > 38°C or < 36°C,
(2) heart rate > 90 beats/min, (3) respiratory rate > 20
breaths/min or PaCo2 < 32 mmHg, and (4) WBC
count > 12,000/μl or < 4,000/μl [8]. When patients ful-
filled the criteria of SIRS, the time was recorded as first
recognition. Patients who needed to receive mechanical
ventilation and/or had serum Cr levels above 4.0 mg/dl
or total bilirubin levels above 5.0 mg/dl were consid-
ered to have respiratory failure, renal failure, or hepatic
failure, respectively. The time of intubation or blood
sampling was regarded as the first recognized time of
organ failure. We defined shock as systolic blood pres-
sure below 90 mmHg or the necessity of the adminis-
tration > 5 μgkg-1 min-1 dopamine, dobutamine, or any
dose of nor-adrenaline, even if sufficient fluids were
infused. When patients fulfilled at least one of the cri-
teria of organ failure or septic shock, the time was
recorded as first recognition.
Any patient who was diagnosed with sepsis and admitted
to the 11-bed medical and surgical ICU of Kumamoto
University Hospital was enrolled in this study if he or
she fulfilled the criteria for sepsis with organ failure or
sepsis with shock. DSOF was defined as the duration
from the initial recognition of SIRS to the first recognition
of organ failure or shock (Figure 1) and was calculated onFigure 1 Schematic representation of the progressive course of
infection. Sepsis without organ failure or shock in the early stage
progresses to severe sepsis or septic shock in the advanced stage.
Sepsis was defined as an infection with systemic inflammatory
response syndrome (SIRS). Severe sepsis and septic shock were
defined as sepsis with any organ failure and sepsis with shock,
respectively. Duration of SIRS before organ failure (DSOF) was
defined as the duration from the first recognition of SIRS to the first
recognition of organ failure or septic shock.the basis of accurate medical records. Various data were
recorded on recognition of organ failure or shock: gender;
age; shock or not shock; underlying diseases; localization of
the primary infection; whether the patient came from the
general ward in our hospital or from another hospital;
whether the patient was post-surgical; blood pressure;
heart rate; respiratory rate; bacterial species; arterial blood
gas, including pH and PaO2; and venous blood parameters.
Neurological evaluations were performed using the Glas-
gow Coma Scale (GCS). APACHE II and SOFA scores
were calculated as described [5,12]. We defined DIC per
the revised criteria of the Japanese Association for Acute
Medicine (JAAM) [13,14]. Various prognostic factors were
evaluated for the endpoint of in-hospital mortality of the
septic patients.
As the treatment of sepsis, removal or drainage of the
infection sites and adequate antimicrobial therapy were
performed as soon as possible [3,15-17]. Mechanical
ventilation for sepsis-induced acute lung injury (ALI)/
acute respiratory distress syndrome (ARDS) and fluid re-
suscitation and the administration of catecholamine for
maintaining circulation for septic shock are performed
in septic patients to prevent the development of a more
critical condition resulting in MOF and death [8,18-20].
The treatment of sepsis was performed according to the
Surviving Sepsis Campaign guideline [8,21].
Statistical analysis
The relationship between risk factors and death was first
examined by univariate analysis using the two-sample
unpaired Student’s t-test for parametric continuous vari-
ables, Mann–Whitney U-test for nonparametric con-
tinuous variables, and Pearson’s chi-square test for
categorical variables. Multivariate logistic regression was
performed to determine independent risk factors for in-
hospital mortality. Risk factors with p-values < 0.2 by
univariate analysis were put into the multivariate logistic
regression. The SOFA score was not included in the multi-
variate analysis because it has a relationship with APACHE
II scores. We analyzed the survival between patients with
DSOF ≤24 h and DSOF >24 h by using Kaplan-Meier sur-
vival curves, and the significance was tested by log-rank
test. All statistical analyses were performed using SPSS for
Windows (Release 13.0; SPSS Inc., Chicago, IL). Two-tailed
p-values <0.05 were considered significant.
Results and discussion
Results
Of the 118 patients who were enrolled initially, we
excluded 5 patients who had uncertain records regarding
the first recognition of SIRS and 3 patients younger than
15 years. Thus, the final group for evaluation comprised
110 patients. The mean age of the patients (72 men and
38 women) was 63.3 ± 1.4 years (range 16–88 years).
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patients with shock, organ failure, and both, respect-
ively. The types of organ failure were respiratory fail-
ure (70 patients), renal failure (8 patients), and hepatic
failure (3 patients). The mean ICU and mean hospital
stays were 15.5 ± 2.4 days and 54.1 ± 5.0 days, respect-
ively. The mean APACHE II and SOFA scores at ad-
mission were 22.6 ± 0.7 and 8.92 ± 0.38, respectively.
The mean and median DSOFs were 68.9 ± 8.5 h and
28.5 h (range 0–456 h), respectively. The in-hospital
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DSOF (≤ 24 h)
DSOF (≤ 48 h)Table 1 shows the univariate analysis of various factors
and variables as prognostic factors. As a metric variable,
DSOF was a statistically significant prognostic factor, as
were age, APACHE II score, SOFA score, AT III, BUN,
and pneumonia.
Figure 2A shows the number of survivors and non-
survivors for each DSOF value. The mortality rate was
higher in patients with shorter DSOFs. The receiver-
operating characteristic (ROC) curve and area under
ROC curve (AUC) show that DSOF is a significant prog-
nostic factor as are the APACHE II and SOFA scores.tality
Non-survivors (n = 41) Survivors (n = 69) P value
30 (73.2) 42 (60.9) 0.190
69.3 ± 1.7 59.7 ± 1.8 0.001
26.6 ± 0.1 20.3 ± 0.8 < 0.001
10.1 ± 0.7 8.3 ± 0.4 0.040
4.5 ± 0.32 4.37 ± 0.25 0.776
24 (58.5) 35 (50.7) 0.427
27 (58.5) 37 (53.6) 0.209
3 (11.1) 3 (7.9)
4 (14.8) 9 (23.7)
6 (22.2) 6 (15.8)
8 (29.6) 10 (26.3)
4 (14.8) 5 (13.2)
1 (3.7) 1 (2.6)
1 (3.7) 3 (7.9)
16 (39.0) 34 (49.3)
19 (46.3) 19 (27.5) 0.045
5 (12.2) 10 (14.5)
1 (2.4) 6 (8.7)
22 (53.7) 37 (53.6) 0.997
8 (19.5) 21 (30.4) 0.209
14 / 27 (51.9) 22 / 50 (44.0) 0.510
12.8 ± 3.5 21.5 ± 6.4 0.125
11.0 ± 0.6 11.6 ± 0.4 0.432
43.3 ± 4.2 32.7 ± 2.7 0.012
2.12 ± 0.21 1.64 ± 0.17 0.051
3.44 ± 0.77 2.70 ± 0.57 0.175
47.6 ± 3.1 63.1 ± 2.7 0.001
412 ± 33 463 ± 18 0.295
11.6 ± 1.5 13.6 ± 1.6 0.619
17.4 ± 1.4 16.6 ± 1.1 0.625
31.0 ± 1.2 29.6 ± 0.7 0.422
58.8 ± 16.5 74.7 ± 9.6 0.015
26 (63.4) 24 (34.8) 0.004
30 (73.2) 38 (55.1) 0.059
Figure 2 A. The number and mortality rates of patients by DSOF. B. ROC curve for DSOF, APACHE II, and SOFA scores for distinguishing
non-survivors from patients with severe sepsis.
Sugita et al. International Journal of Emergency Medicine 2012, 5:44 Page 4 of 7
http://www.intjem.com/content/5/1/44On the basis of the ROC curve, we defined the DSOF
cutoff as 24 h (Figure 2B). Thus, we divided the patients
into two groups: group 1 consisted of patients with a
DSOF of 24 h or less (≤24 h), and group 2 comprised
those with a DSOF of more than 24 h (>24 h).
In-hospital mortality rates differed significantly between
the two groups (52.0% vs. 25.0%, p = 0.004). Figure 3 shows
the Kaplan-Meier survival curves. The mortality rate in
group 1 was greater than that of group 2 (log rank test,
p <0.005).
Table 2 shows the characteristics of groups 1 and 2.
The mean age in group 1 was higher than in group 2.
SOFA scores and hematocrit, serum creatinine, and
serum BUN levels in group 1 were significantly higherFigure 3 Kaplan-Meier survival curves of septic patients
with organ failure or shock. The survival rate of the patients
with DSOF ≤24 h was significantly smaller compared to that of the
patients with DSOF >24 h (log rank test, P < 0.005). The solid line
indicates group 1 (DSOF ≤24 h), and the dashed line denotes group
2 (DSOF >24 h).than in group 2. The incidence of septic shock was sta-
tistically greater in group 1 than in group 2.
We analyzed the mortality rate in each subgroup on the
basis of the primary infection site (Table 3). In patients
with pneumonia, the in-hospital mortality rate in group 1
was significantly higher than in group 2. In the other sub-
groups, the in-hospital mortality rate was generally higher
in group 1 than in group 2 (not significant).
In the patients infected with E coli or Streptococcus
spp., the incidence was significantly greater in group 1
than in group 2. Conversely, there were significantly
fewer non-survivors than survivors among the patients
who were infected with E coli, while those with Strepto-
coccus spp. tended to have high mortality rates (Table 4).
Various prognostic factors were analyzed by multivariate
analysis using logistic regression. Table 5 shows the inde-
pendent prognostic factors at the time of recognition of
organ failure or shock. DSOF ≤24 h (odds ratio: 5.37, 95%
confidence interval: 1.36–21.24, p = 0.017) was a significant
prognostic factor of in-hospital mortality, as were APA-
CHE II score, AT III levels, age, and pneumonia. As a
metric variable, DSOF is not a statistically significant prog-
nostic factor according to multivariate analysis.
Discussion
We developed and defined the DSOF—calculated using
clinical parameters—and evaluated its value as a prog-
nostic factor (Figure 1). Our results demonstrate that
as a metric variable, DSOF is a significant prognostic
factor by univariate analysis and that the in-hospital
mortality rate in patients with DSOF ≤24 h is signifi-
cantly higher than in those with DSOF >24 h. In
addition, a DSOF of ≤24 h is an independent prognos-
tic factor in septic patients, as are APACHE II score,
AT III levels, age, and primary infection in the lung
according to multivariate analysis.
Table 2 Patient characteristics in groups 1 and 2
Characteristic Group 1 (n = 50) Group 2 (n = 60) P value
Age, years 66.8 ± 1.6 60.3 ± 2.1 0.048
Gender (men) 32 ( 64.0 ) 40 (66.7) 0.770
APACHE II score 23.3 ± 1.0 22.1 ± 0.9 0.463
SOFA score 9.88 ± 0.51 8.12 ± 0.52 0.014
DIC score 4.47 ± 0.28 4.38 ± 0.28 0.798
Shock 32 ( 64.0) 27 (45.0) 0.047
Severe underlying disease 29 (58.0) 36 (60.0) 0.832
Chronic cardiac insufficiency 1 5 0.145
Diabetes mellitus 8 5 0.215
Hepatic cirrhosis 8 4 0.118
Neoplasm 3 6 0.446
Immunosupression 6 12 0.259
Chronic renal insufficiency 2 0 0.118
Chronic pulmonary insufficiency 1 3 0.403
Localization of primary infection
Abdomen 24 (48.0) 26 (43.3) 0.625
Lung 13 (26.0) 25 (41.7) 0.085
Soft tissue 9 (18.0) 6 (10.0) 0.223
Other 4 (8.0) 3 (5.0) 0.521
AT III (%) 56.6 ± 3.4 57.9 ± 2.9 0.643
Cr (mg/dl) 2.28 ± 0.21 1.43 ± 0.16 < 0.001
BUN (mg/dl) 41.9 ± 3.6 32.7 ± 3.0 0.018
Group 1: patients with a DSOF of 24 h or less (≤24 h); group 2: patients with a DSOF of more than 24 h (>24 h).
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and the recognition of SIRS. The time lag may be less than
a few hours. This may be a limit of this study. However, no
physician can know the true development of SIRS in clin-
ical practice. Thus, we employed the recognition time of
SIRS in the present study. DSOF denotes the speed of pro-
gression from early to advanced-stage sepsis. Various fac-
tors, including host defense and its response to infection,
the strength of the bacterial toxin, and treatment efficacy,
influence the DSOF. Severe underlying diseases and condi-
tion such as diabetes mellitus, liver cirrhosis, and immuno-
suppression are implicated in the patient’s prognosis,
although we did not observe any significance in this study
[10,15,22-26].Table 3 Mortality rate in subgroups
Origin of infection Group 1 (n = 50) Group 2 (n = 60) P value
Pneumonia 12/13 (92.3) 7/25 (28.0) <0.001
Panperitonitis 5/14 (35.7) 3/7 (42.9) 0.751
Biliary tract infection 2/6 (33.3) 1/10 (10) 0.247
Necrotizing fasciitis 5/8 (62.5) 0/2 (0) 0.114
Others 3/9 (33.3) 3/16 (18.8)
Group 1: patients with a DSOF of 24 h or less (≤24 h).
Group 2: patients with a DSOF of more than 24 h (>24 h).Septic patients with long DSOFs might tolerate bac-
teria. However, the type of bacteria and toxin is impli-
cated in the DSOF-based prognosis. For example,
Streptococcus spp. infection caused a short DSOF and
poor prognosis in this study. Thus, the DSOF might re-
flect the host response and the strength of the bacteria.
The wide range in DSOFs causes the difficulty in stat-
istical evaluation. We defined an optimal cutoff of 24 h
with which we divided the patients and compared mor-
tality rates. Further, we compared the characteristics be-
tween groups 1 and 2 to determine the factors that
influence the DSOF. Age might significantly influence
DSOF. The higher incidence of shock in group 1 than
group 2 suggests that the progression from SIRS to
shock is more rapid than the progression from SIRS to
organ failure. The deterioration of renal function in
group 1 patients might be attributed to shock. Further-
more, the higher SOFA scores in group 1 might be
attributed to renal dysfunction and shock.
We examined various prognostic factors of severe sep-
sis and septic shock by multivariate analysis and found
that age, APACHE II score, AT III, and pneumonia are
independent prognostic factors, consistent with previous
reports [2,3,10,27]. Our results suggest that the DIC
score at the time of ICU admission has no prognostic
Table 4 Bacterial species and DSOF
Bacteria Number of patients Number of patients
DSOF ≤24 h DSOF >24 h P Non-survivor survivor P
MRSA* 4 11 5 10
Streptococcus spp. 8 2 0.04 7 3 0.07
Pseudomonas aeruginosa 2 7 5 4
Escherchia coli 7 1 0.016 0 8 0.02
Enterococcus spp. 2 5 2 5
Vibrio vulnificus 5 1 0.06 3 3
Klebsiella spp. 2 4 2 4
Enterobacter spp. 1 4 1 4
Stenotrophomonas maltophilia 2 2 3 1
Haemophilus influenzae 1 1 0 1
Legionella pneumophila 0 2 0 2
MSSA** 0 2 0 2
Staphylococcus epidermidis 2 0 1 1
Bacillus spp. 1 0 0 1
Bacteroides spp. 0 1 0 1
Corynebacterium spp. 1 0 1 0
Morganella morganii 0 1 0 1
Mycobacterium spp. 0 1 1 0
Salmonella spp. 0 1 1 0
Serratia marcescens 0 1 1 0
Acinetobacter spp. 1 0 1 0
Fungus 2 5 2 5
Others 2 1 1 2
Unknown 11 8 7 12
Total 53 61 44 70
*MRSA: methicillin-resistant Staphylococcus aureus.
**MSSA: methicillin-sensitive Staphylococcus aureus.
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tic factor of organ failure [14,22]. These results indicate
that the progression of DIC is slower than circulatory
failure and respiratory failure in many cases and that
early organ failure is not dependent on DIC. WeTable 5 Multivariate analysis of risk factors for in-hospital
mortality
Risk factor In-hospital mortality OR (95% CI) P Value
DSOF (≤ 24 h) 5.371 (1.358-21.235) 0.017
Pneumonia 11.494 (2.347-55.556) 0.003
APACHE II score 1.189 (1.060-1.334) 0.003
AT III 0.956 (0.923-0.991) 0.013
Age 1.068 (1.014-1.125) 0.021
Gender (female) 0.388 (0.101-1.381) 0.153
T-bilirubin 1.030 (0.921-1.153) 0.602
BUN 0.994 (0.961-1.028) 0.717
Cr 0.911 (0.496-1.675) 0.765analyzed DSOFs by the primary location of infection. In
septic patients in whom the primary infection was the
lung, DSOF ≤24 h was a significant prognostic factor of
in-hospital mortality. However, our data show that the
DSOF in patients with peritonitis was shorter than that
in other subgroups, and the mortality rate in patients
with DSOF ≤24 h is not greater than in patients with
DSOF >24 h. These results indicate that pan-peritonitis
progresses more rapidly than other diseases, and the
patient’s prognosis may depend on the surgical proced-
ure and treatment after surgery. Analysis of a cohort of
septic patients showing different types of sepsis may
cause wide variations in DSOF. Thus, additional sub-
group analyses are necessary.
DSOF may be dependent on the accuracy of the first
detection of sepsis. Thus, the patients with infection
should be observed carefully. However, the detection of
SIRS in in-patients is not difficult. The Delta SOFA
score, which measures the progression of organ failure,
is an excellent prognostic factor, but it is not available
Sugita et al. International Journal of Emergency Medicine 2012, 5:44 Page 7 of 7
http://www.intjem.com/content/5/1/44until a few days after the patients have organ failure and
have been admitted to the ICU [28,29]. In contrast,
DSOF can be calculated at the time of recognition of
organ failure. DSOF may be a promising prognostic fac-
tor for patients with severe sepsis. There is no correl-
ation between the DSOF and APACHE II score. Thus,
the combination of DSOF and APACHE II score may be
more useful for determining the patients with poor
prognosis.
Conclusions
DSOF may be a promising prognostic factor for the
patients with severe sepsis. Further clinical studies are
necessary.
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